SOX4在消化系统恶性肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2022.04.014

摘要/Abstract

摘要： SOX4是SOX家族C组亚科的成员,它可能通过赋予癌细胞生存、迁移和侵袭能力来促进肿瘤发生发展。目前已有多种证据支持SOX4是一种重要的癌基因的观点。SOX4在多种恶性肿瘤中过表达,包括消化系统肿瘤,而消化系统肿瘤是发展中国家癌症患者死亡的最常见原因。近年来,SOX4引起恶性转化的分子机制及其与消化系统肿瘤的关系成为研究的焦点和前沿领域。本文就SOX4在消化系统肿瘤中的研究现状进行综述。

关键词: SOX4基因, 消化系统肿瘤, 恶性肿瘤

Abstract: SOX4 is a member of the group C subfamily from the SOX family,and it may promote tumorigenesis by conferring the ability of cancer cells to survive,migrate and invasive.There are multiple lines of evidence supporting the idea that SOX4 is an important oncogene.SOX4 is overexpressed in a variety of malignancies,including a variety of digestive system tumors,which are the most common cause of death among cancer patients in developing countries.In recent years,the molecular mechanism of SOX4-induced malignant transformation and its relationship with digestive system tumors have become a focus of research and a frontier area.This article reviews the research status of SOX4 in digestive system tumors.

Key words: SOX4 gene, Digestive system tumors, Malignant tumor

中图分类号:

R735

赵梓楠, 王国年. SOX4在消化系统恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(4): 364-368.

ZHAO Zinan, WANG Guonian. Research progress of SOX4 in digestive system malignant tumors[J]. Journal of Practical Oncology, 2022, 36(4): 364-368.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.04.014

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I4/364

参考文献

1 Hanieh H,Ahmed EA,Vishnubalaji R,et al.SOX4:epigenetic regulation and role in tumorigenesis-ScienceDirect[J].Semin Cancer Biol,2020,67:91-104.
2 Andersen CL,Christensen LL,Thorsen K,et al.Dysregulation of the transcription factors SOX4,CBFB and SMARCC1 correlates with outcome of colorectal cancer[J].Br J Cancer,2009,100(3):511-523.
3 Fischer KR,Durrans A,Lee S,et al.Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance[J].Nature,2015,527:472-476.
4 邢静,林耿鹏,罗海丹,等.M3R激动剂通过激活PI3K/AKT信号途径促进肺癌细胞A549的上皮间质转化[J].中国病理生理杂志,2018,34(3):423-427.
5 LourençO AR,Coffer PJ.SOX4:joining the master regulators of epithelial-to-mesenchymal transition[J].Trends in Cancer,2017,3(8):571-582.
6 Li L,Liu J,Xue H,et al.A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis[J].Oncogene,2019,39(1):1-15.
7 Hu WB,Wang L,Huang XR,et al.MicroRNA-204 targets SOX4 to inhibit metastasis of lung adenocarcinoma[J].Eur Rev Med Pharmaco,2019,23(4):1553-1562.
8 Noce ML,Paino F,Mele L,et al.HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo:a study on a putative new target for CSCs directed therapy[J].J Exp Clin Canc Res,2018,37(1):296.
9 Castro-Oropeza R,Melendez-Zajgla J,Maldonado V,et al.The emerging role of lncRNAs in the regulation of cancer stem cells.[J].Cellular oncology(Dordrecht),2019,41(6):585-603.
10 Lin Q,Wu Z,Yue X,et al.ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation[J].E Bio Medicine,2020,53:102676.
11 Ebrahim AS,Sabbagh H,Liddane A,et al.Hematologic malignancies:newer strategies to counter the BCL-2 protein.[J].J Cancer Res Clin Oncol,2016,142(9):2013-2022.
12 Foronda M,Martínez P,Schoeftner S,et al.SOX4 links tumor suppression to accelerated aging in mice by modulating stem cell activation[J].Cell Reports,2014,8(2):487-500.
13 Lu P,Meng L,Feng L,et al.miR-188 suppresses tumor progression by targeting SOX4 in pediatric osteosarcoma[J].Mol Med Rep,2019,18(1):441-446.
14 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
15 Llovet JM,Kelley RK,Villanueva A,et al.Hepatocellular carcinoma[J].Nat Rev Dis Primers,2021,7(1):6.
16 Sandbothe M,Buurman R,Reich N,et al.The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4[J].J Hepatol,2017,66(5):1012-1021.
17 Tsai CN,Yu SC,Lee CW,et al.SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo[J].Oncogene,2020,39(24):4695-4710.
18 Gao PT,Ding GY,Yang X,et al.Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4[J].Am J Cancer Res,2018,8(6):1040-1049.
19 Wang H,Huo X,Yang XR,et al.STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4[J].Mol Cancer,2017,16(1):136.
20 Chen Y,Huang F,Deng L,et al.Long non‐coding RNA TGLC15 advances hepatocellular carcinoma by stabilizing Sox4[J].J Clin Lab Anal,2020,34(2):e23009.
21 Smyth,EC,Nilsson M,Grabsch HI,et al.Gastric cancer[J].Lancet,2020,396(10251):635-648.
22 Wang Q,X Mao,Luo F,et al.LINC00511 promotes gastric cancer progression by regulating SOX4 and epigenetically repressing PTEN to activate PI3K/AKT pathway[J].J Cell Mol Med,2021,25(19):9112-9127.
23 Sun Y,Han C.Long non-coding RNA TMPO-AS1 promotes cell migration and invasion by sponging miR-140-5p and inducing SOX4-mediated EMT in gastric cancer[J].Cancer Manag Res,2020,12:1261-1268.
24 Zhang J,Zhang K,Hou Y.Long non-coding RNA NNT-AS1 knockdown represses the progression of gastric cancer via modulating the miR-142-5p/SOX4/Wnt/β-catenin signaling pathway[J].Mol Med Rep,2020,22(2):687-696.
25 Ding L,Zhao Y,Dang S,et al.Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4[J].Mol Cancer,2019,18(1):45.
26 Liu L,Dong T,Sheng J.Propofol suppresses gastric cancer progression by regulating circPDSS1/miR-1324/SOX4 axis[J].Cancer Manag Res,2021,13:6031-6043.
27 Yokose T,Kitago M,Matsuda S,et al.Combination of KRAS and SMAD4 mutations in formalin‐fixed paraffin‐embedded tissues as a biomarker for pancreatic cancer[J].Cancer Science,2020,111(6):2174-2182.
28 David C,Huang YH,Mo C,et al.TGF-β tumor suppression through a lethal EMT[J].Cell,2016,164(5):1015-1030.
29 Huang YH,Hu J,Chen F,et al.ID1 Mediates escape from TGFβ tumor suppression in pancreatic cancer[J].Cancer Discovery,2020,10(1):142-157.
30 RL Siegel,KD Miller,AG Sauer,et al.Colorectal cancer statistics,2020[J].CA Cancer J Clin,2020,70(3):145-164.
31 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,1(41):19-28.
32 Mou TY,Zhang RR,Wang YN,et al.MiRNA-212 acts as a tumor-suppressor in colorectal carcinoma through targeting SOX4[J].Eur Rev Med Pharmaco,2019,23(24):10751-10760.
33 Thi H,Kim HY,Kim YM,et al.MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4[J].Neoplasia,2019,21(9):882-892.
34 Deng H,Wang M,Xu Q,et al.ZFAS1 promotes colorectal cancer metastasis through modulating miR-34b/SOX4 targeting[J].Cell Biochem Biophys,2021,79(2):387-396.
35 Chen Z,Zhong T,Zhong J,et al.MicroRNA129 inhibits colorectal cancer cell proliferation,invasion and epithelialtomesenchymal transition by targeting SOX4[J].Oncol Rep,2021,45(5):61.
36 Rezayi Soufiani A,Dolatkhah R,Raeisi M,et al.Hypermethylation of MIR129-2 regulates SOX4 transcription and associates with metastasis in patients with colorectal cancer[J].J Gastric Cancer,2021,10:1007.
37 Gomes AP,Ilter D,Low V,et al.Age-induced accumulation of methylmalonic acid promotes tumour progression[J].Nature,2020,585(7824):283-287.
38 Chen X,Xu M,Xu X,et al.METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer[J].Mol Cancer,2020,19(1):106.
39 Liu J,Qiu J,Zhang Z,et al.SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study[J].Cell Biosci,2021,11(1):23.
40 Qin Y,Zhao W,Cheng L,et al.Evaluation of the correlativity of gender determining region Y-box 4,N-cadherin,CD44 and E-cadherin expression in the prognosis of esophageal squamous cell carcinoma[J].Int J Clin Exp Patho,2019,12(5):1745-1756.
41 刘慧敏,乔丽颖,钱永刚,等.内蒙古2016年食管癌发病和死亡现状及2012—2016年趋势分析[J].实用肿瘤学杂志,2021,35(4):351-356.
42 符立平,顾春荣,熊佳时,等.SOX4抑制凋亡介导食管癌顺铂耐药的实验研究[J].肿瘤预防与治疗,2017,30(3):158-163.
43 刘本鲲,徐世东,孙大为.TGF-β在肿瘤微环境中多重作用的研究进展[J].实用肿瘤学杂志,2015,29(5):454-457.

[1]	李原, 张玲. 消化系统肿瘤发生有丝分裂危象的研究进展[J]. 实用肿瘤学杂志, 2022, 36(4): 356-359.
[2]	吴芳芳, 郑桐森. 胆道恶性肿瘤辅助治疗的研究现状及展望[J]. 实用肿瘤学杂志, 2022, 36(2): 156-161.
[3]	唐菊, 尚利华. BMI与免疫检查点抑制剂治疗恶性肿瘤疗效的关系[J]. 实用肿瘤学杂志, 2022, 36(2): 188-192.
[4]	王艳平, 邱琳, 武萌, 飒日娜. 2016年陕西省恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2022, 36(1): 1-6.
[5]	李娜, 邓茜, 蒋建军. NF-κB信号通路在恶性肿瘤化疗耐药中的作用[J]. 实用肿瘤学杂志, 2021, 35(6): 580-584.
[6]	符艳, 颜李丽, 王春雨, 符芳敏, 董华. 2010—2016年琼海市恶性肿瘤流行情况分析[J]. 实用肿瘤学杂志, 2021, 35(5): 396-401.
[7]	商昌权, 李国东, 魏九峰, 刘明. MCM蛋白在消化系统肿瘤的研究进展[J]. 实用肿瘤学杂志, 2021, 35(5): 431-435.
[8]	金升烨, 庞达. 溶瘤病毒诱导肿瘤凋亡及激活抗肿瘤免疫机制的研究进展[J]. 实用肿瘤学杂志, 2021, 35(5): 462-467.
[9]	范琳, 田霖丽, 刘鸣. 单细胞测序技术在头颈部恶性肿瘤中的研究与发展[J]. 实用肿瘤学杂志, 2021, 35(5): 472-475.
[10]	董华, 王定彬, 华婧, 范康琼, 马楠楠, 王兴任. 2016年海南省肿瘤登记地区恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2021, 35(4): 344-350.
[11]	陈莉莉, 刘玉琴, 丁高恒, 苏海翔. 甘肃省恶性肿瘤流行情况及防控现状[J]. 实用肿瘤学杂志, 2021, 35(3): 254-257.
[12]	马明瑞, 连洁, 刘超, 娄长杰, 张艳桥. 消化系统肿瘤“免疫治疗前移”的探索[J]. 实用肿瘤学杂志, 2021, 35(3): 258-262.
[13]	国昊楠, 秦韬. MYO10与恶性肿瘤的研究进展[J]. 实用肿瘤学杂志, 2021, 35(3): 273-276.
[14]	潘红艳, 李爱萍, 李强. 脂肪因子Omentin-1与肿瘤相关性的研究[J]. 实用肿瘤学杂志, 2021, 35(3): 282-286.
[15]	郑志远,综述,曲国蕃(审校). 长链非编码RNA SNHG3在恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 50-54.